Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03187535 · ClinicalTrials.gov registry record · NA
Effect of TEAS on PONV After Spinal Surgery
A NA study of PONV, sponsored by Jyoti Pandya.
- Recruiting
- Registry status
- NA
- Development phase
- 72
- Enrollment target
- 1
- Study location
NCT03187535: Recruiting NA study of PONV, sponsored by Jyoti Pandya.
NCT03187535 is a NA study of PONV that is actively recruiting participants, run by Jyoti Pandya. The registered enrollment target is 72 participants, below the 525-participant average among 3 other PONV trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03187535, a NA study of PONV, is actively recruiting participants, sponsored by Jyoti Pandya.
- RECRUITING
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed research will utilize electroacupuncture, a type of needleless acupuncture that uses electrostimulation, in a randomized, double blind study, to evaluate the incidence of post-operative nausea and vomiting (PONV) in patients undergoing spinal surgeries with the transcutaneous electrical acupoint stimulation (TEAS) compared to patients without TEAS.
Primary Outcome
measure the incidence of PONV in spinal surgery
Conditions Studied
Interventions
- DEVICE TEAS via ES-130
- OTHER No TEAS
Study Locations (1)
Ohio
- The Ohio State University Wexner Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2026-12-20 |
| Phase | NA |
What NCT03187535 shows while recruiting
NCT03187535 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 525-participant average among 3 other PONV trials with a reported enrollment target (86% lower).
The record links to 1 condition, with PONV appearing as the primary indexed condition, and to 2 interventions - of which TEAS via ES-130 is the first listed.
NCT03187535 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03187535 about?
NCT03187535 is a clinical study titled "Effect of TEAS on PONV After Spinal Surgery". The proposed research will utilize electroacupuncture, a type of needleless acupuncture that uses electrostimulation, in a randomized, double blind study, to evaluate the incidence of post-operative nausea and vomiting (PONV) in patients undergoing spinal surgeries with the transcutaneous electrical...
What is the current status of trial NCT03187535?
This trial is currently recruiting. It is a NA study. The enrollment target is 72 participants. The study started on 2018-08-01. Estimated completion is 2026-12-20.
What conditions does trial NCT03187535 study?
This clinical trial studies the following conditions: PONV.
What interventions are being tested in trial NCT03187535?
The interventions under investigation include: TEAS via ES-130 (DEVICE), No TEAS (OTHER).
Who is sponsoring clinical trial NCT03187535?
This trial is sponsored by Jyoti Pandya, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03187535 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PONV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03747458 · 72 participants · Phase 3
OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI